Asahi Life Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-9,510
| Closed | -$538K | – | 165 |
|
2024
Q4 | $538K | Buy |
+9,510
| New | +$538K | 0.33% | 55 |
|
2023
Q4 | – | Sell |
-4,150
| Closed | -$241K | – | 162 |
|
2023
Q3 | $241K | Buy |
+4,150
| New | +$241K | 0.08% | 161 |
|
2023
Q2 | – | Sell |
-3,730
| Closed | -$259K | – | 193 |
|
2023
Q1 | $259K | Buy |
3,730
+2,150
| +136% | +$149K | 0.08% | 168 |
|
2022
Q4 | $114K | Hold |
1,580
| – | – | 0.04% | 185 |
|
2022
Q3 | $112K | Hold |
1,580
| – | – | 0.03% | 222 |
|
2022
Q2 | $122K | Buy |
1,580
+230
| +17% | +$17.8K | 0.03% | 227 |
|
2022
Q1 | $99K | Sell |
1,350
-10,520
| -89% | -$771K | 0.01% | 182 |
|
2021
Q4 | $740K | Buy |
11,870
+250
| +2% | +$15.6K | 0.09% | 59 |
|
2021
Q3 | $688K | Sell |
11,620
-740
| -6% | -$43.8K | 0.09% | 58 |
|
2021
Q2 | $826K | Sell |
12,360
-1,450
| -10% | -$96.9K | 0.11% | 50 |
|
2021
Q1 | $872K | Buy |
13,810
+6,010
| +77% | +$379K | 0.12% | 48 |
|
2020
Q4 | $484K | Sell |
7,800
-150
| -2% | -$9.31K | 0.06% | 117 |
|
2020
Q3 | $479K | Buy |
7,950
+150
| +2% | +$9.04K | 0.07% | 74 |
|
2020
Q2 | $459K | Sell |
7,800
-7,550
| -49% | -$444K | 0.08% | 72 |
|
2020
Q1 | $856K | Buy |
15,350
+1,020
| +7% | +$56.9K | 0.15% | 49 |
|
2019
Q4 | $920K | Buy |
14,330
+1,670
| +13% | +$107K | 0.14% | 45 |
|
2019
Q3 | $642K | Buy |
12,660
+1,240
| +11% | +$62.9K | 0.1% | 56 |
|
2019
Q2 | $518K | Sell |
11,420
-2,460
| -18% | -$112K | 0.1% | 72 |
|
2019
Q1 | $662K | Sell |
13,880
-310
| -2% | -$14.8K | 0.11% | 63 |
|
2018
Q4 | $738K | Buy |
+14,190
| New | +$738K | 0.12% | 53 |
|